MAD SSCi is returning to New Brunswick, New Jersey! Join 150+ core directors, staff, administrators, and vendors for a day of networking, technical insights, and honest conversation about what it takes to run a successful biomedical core facility.
Meet biomodal at our table
Stop by to talk with Steven Ciaramaglia, Territory Account Manager, about the technology that delivers genome and epigenome data in a single workflow.
Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all 4 canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. The 6-base genome enables multidimensional DNA methylation analysis for biomarker discovery to gain transformative insights into current and future states of disease.
Take first look at biomodal’s newly launched duet mosaic™ family, new workflows for cfDNA and liquid biopsy research that combine genetic, epigenetic, and fragmentomic information from the same molecules, including short, damaged fragments other workflows may miss.
Come find the biomarkers you’ve been searching for and finally, see it all.
